HOME >> MEDICINE >> NEWS
Promising new treatment options for people with co-existing alcohol-use and psychiatric disorders

Individuals who have co-existing alcohol-use and psychiatric disorders must overcome a number of significant hurdles on their way to recovery: multiple health and social problems, double the stigma, a poor response to traditional treatments, a lack of joint treatment options, and a chronic cycle of treatment entry and re-entry. Symposium proceedings published in the February issue of Alcoholism: Clinical & Experimental Research examine treatment options for this group, with a focus on four major psychiatric disorders: social anxiety disorder, depression, bipolar disorder, and schizophrenia.

"The United States has typically separated services for mental health from those associated with addictions," said Charlene E. Le Fauve, symposium organizer and health scientist administrator at the National Institute on Alcohol Abuse and Alcoholism. "Because of this separation, when a person with comorbid disorders enters one type of care, they are inadequately treated for the other condition. If one disorder goes untreated, both usually worsen and additional complications occur, which can include serious medical problems such as liver disease, HIV, or other organ damage, suicide, criminalization, unemployment, and homelessness. As a result, some individuals with comordid disorders often require high-cost services such as inpatient and emergency room care."

Symposium speakers at the June 2003 Research Society on Alcoholism meeting in Fort Lauderdale, Florida presented findings from recent trials and clinical studies:

  • A selective serotonin reuptake inhibitor (SSRI) called paroxetine shows promise in the treatment of social anxiety in alcohol-dependent subjects.

    "Since this was the first study to examine the effectiveness of paroxetine in this dual-diagnosis population," said Le Fauve, "we need to see if the results can be replicated by other researchers before we can determine how promising the results are."

  • Response to S
    '"/>



  • 15-Feb-2004


    Page: 1 2 3 4

    Related medicine news :

    1. Promising new strategy for Swedish medical research
    2. Promising treatments for Huntingtons disease identified in UCI study
    3. Promising results for malaria vaccine trial
    4. Promising diagnostic test for sleeping sickness
    5. Promising drug fails to thwart fatal lung disease in large trial
    6. Promising drug proves ineffective as treatment for hearing loss
    7. Promising West Nile virus vaccine protects monkeys
    8. Promising new treatment preserves bone mass in mice; May help women and men with osteoporosis
    9. Promising vaccine may provide long-lasting protection against malaria
    10. Promising new research on schizophrenia causes
    11. UI Study Suggests Promising Treatment For Diabetic Pregnancies

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:4/30/2017)... ... April 30, 2017 , ... PracticeMatch, a company that provides healthcare recruiting resources ... year’s physician career fairs, with this year’s RSVPs and registrations so far tracking a ... year of national physician career fairs is located on the PracticeMatch website. ...
    (Date:4/29/2017)... , ... April 29, 2017 , ... TransDark is a ... from one video to the next without having to set a single keyframe in ... transitions to enhance your video production. , TransDark features dynamic transitions that momentarily splits ...
    (Date:4/29/2017)... ... 2017 , ... Saturday, April 29, marks World Veterinary Day, ... on animal health and welfare as well as on public health. The World ... theme each year and this year have selected “Antimicrobial Resistance—From Awareness to Action,” ...
    (Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... It's ... there are a number of illnesses that are unclear as to whether or not ... their heads. Bronchitis is one of these illnesses. So, FindaTopDoc took a look into ...
    (Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
    Breaking Medicine News(10 mins):
    (Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
    (Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
    (Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
    Breaking Medicine Technology:
    Cached News: